Finally, we tested and verified that a synthetic PERK inducer, CCT020312, stimulates cholesterol secretion from glioma cells, which could become a potential targeted drug for glioma from both the tumor and TME perspectives. The gene discussed is EIF2AK3; the disease is central nervous system cancer.